Parkinson's Disease Tulip


advertisement
Reply
 
Thread Tools Display Modes
Old 09-30-2010, 11:59 AM #1
soccertese soccertese is offline
Magnate
 
Join Date: Nov 2007
Posts: 2,531
15 yr Member
soccertese soccertese is offline
Magnate
 
Join Date: Nov 2007
Posts: 2,531
15 yr Member
Default Neupro(R) (Rotigotine) Provided Clinically Relevant Improvements in Health-Related Qu

http://www.marketwatch.com/story/neu...30?siteid=nbkh
soccertese is offline   Reply With QuoteReply With Quote

advertisement
Old 09-30-2010, 02:54 PM #2
Fiona Fiona is offline
Member
 
Join Date: Oct 2006
Posts: 492
15 yr Member
Fiona Fiona is offline
Member
 
Join Date: Oct 2006
Posts: 492
15 yr Member
Default

I totally don't get it - this stuff has been on the market for years - why are they just now or still publishing stuff that shows that it actually helps, and even talking about rats even... are we in some kind of time warp.?

Also, they don't mention the extreme side effects of anixety, panic, frustration and more when they abruptly, overnight, took this product off the US market because they forgot to refrigerate it properly during the manufacturing process (I'm not kidding). Then those of us who were on Neupro had no solutions available to us, no safe way to titrate off the stuff, and it took me three weeks of phone calls to the company, lawyers, doctors, pharmarcists, etc. until I finally got the personal cell phone of a top company exec (by chance) who was the first person to even acknowledge that there was a problem. When you pull a product that people will depend on physically if they use it, without providing any backup or any method to even discern if the remainder of their personal supply was defective or not... Well, let me say that the Neupro sense of customer service significantly worsened my quality of life...

rant, rant, rant. Just saying.
Fiona is offline   Reply With QuoteReply With Quote
Old 09-30-2010, 03:58 PM #3
Fiona Fiona is offline
Member
 
Join Date: Oct 2006
Posts: 492
15 yr Member
Fiona Fiona is offline
Member
 
Join Date: Oct 2006
Posts: 492
15 yr Member
Default

soccertese -

rant not directed at you. Just my experience with that company... thanks for providing the info
Fiona is offline   Reply With QuoteReply With Quote
Old 09-30-2010, 04:58 PM #4
soccertese soccertese is offline
Magnate
 
Join Date: Nov 2007
Posts: 2,531
15 yr Member
soccertese soccertese is offline
Magnate
 
Join Date: Nov 2007
Posts: 2,531
15 yr Member
Default

phew!
that's a relief.
soccertese is offline   Reply With QuoteReply With Quote
Old 09-30-2010, 06:40 PM #5
Fiona Fiona is offline
Member
 
Join Date: Oct 2006
Posts: 492
15 yr Member
Fiona Fiona is offline
Member
 
Join Date: Oct 2006
Posts: 492
15 yr Member
Default

Quote:
Originally Posted by soccertese View Post
phew!
that's a relief.
yeah, thought perhaps you'd be worried...(not really!!)

But seriously, does anyone know why they do things like that, publish studies that finds a product "useful" years and years after it's been on the market? Ostensibly that was established before we started using it, and they could use their time and resources towards newer projects. Whoever "they" is.......
Fiona is offline   Reply With QuoteReply With Quote
Old 10-01-2010, 12:19 AM #6
Conductor71's Avatar
Conductor71 Conductor71 is offline
Senior Member
 
Join Date: Jul 2009
Location: Michigan
Posts: 1,474
10 yr Member
Conductor71 Conductor71 is offline
Senior Member
Conductor71's Avatar
 
Join Date: Jul 2009
Location: Michigan
Posts: 1,474
10 yr Member
Default Rats sleep more soundly

Quote:
Originally Posted by Fiona View Post
yeah, thought perhaps you'd be worried...(not really!!)

But seriously, does anyone know why they do things like that, publish studies that finds a product "useful" years and years after it's been on the market? Ostensibly that was established before we started using it, and they could use their time and resources towards newer projects. Whoever "they" is.......
It's called Grasping at Straws Syndrome marked by three cardinal signs: an old drug, lurking patent expiration, a desperate attempt to find a new "benefit". In this case, it looks like they are trying to position it as the agonist that doesn't keep you awake all night. Here is the major find:

Preclinical data showed rotigotine increased depth of sleep in rats.


This stuff would be comical if it weren't so pathetic that they have got nothing else going on than to waste money on this.
Conductor71 is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
Fiona (10-01-2010)
Old 10-01-2010, 07:53 AM #7
GregD's Avatar
GregD GregD is offline
Member
 
Join Date: Aug 2006
Location: Central Ohio
Posts: 488
15 yr Member
GregD GregD is offline
Member
GregD's Avatar
 
Join Date: Aug 2006
Location: Central Ohio
Posts: 488
15 yr Member
Default

Quote:
Originally Posted by Conductor71 View Post
It's called Grasping at Straws Syndrome marked by three cardinal signs: an old drug, lurking patent expiration, a desperate attempt to find a new "benefit". In this case, it looks like they are trying to position it as the agonist that doesn't keep you awake all night. Here is the major find:

Preclinical data showed rotigotine increased depth of sleep in rats.


This stuff would be comical if it weren't so pathetic that they have got nothing else going on than to waste money on this.
As you may recall, Neupro was recalled because it would crystalize before being asorbed into the body. I participated in a study last year to test the "new" formula". My biggest problem was from the adhesive used to keep the patch on.

It is my guess, they are getting ready to bring this product back on the market.

GregD
__________________
"You can't fight City Hall, but you can pee on the steps and run." --Gary North
GregD is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
Fiona (10-01-2010), soccertese (10-01-2010)
Old 10-01-2010, 10:37 AM #8
Conductor71's Avatar
Conductor71 Conductor71 is offline
Senior Member
 
Join Date: Jul 2009
Location: Michigan
Posts: 1,474
10 yr Member
Conductor71 Conductor71 is offline
Senior Member
Conductor71's Avatar
 
Join Date: Jul 2009
Location: Michigan
Posts: 1,474
10 yr Member
Default It requires reformulation

Quote:
Originally Posted by GregD View Post
As you may recall, Neupro was recalled because it would crystalize before being asorbed into the body. I participated in a study last year to test the "new" formula". My biggest problem was from the adhesive used to keep the patch on.

It is my guess, they are getting ready to bring this product back on the market.

GregD
It is being aggressively marketed in Europe now, but I believe the FDA is requiring reformulation before it reappears for patients here. It will not be available before 2012. Source: National Parkinson Foundation

BTW, just me being sarcastic with the above post. Not intended to diss anyone's medication. I tried it and it turned my PD into what looked like Ataxia...one movement disorder at a time, please.

Laura
Conductor71 is offline   Reply With QuoteReply With Quote
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
UCB Receives Complete Response Letter from U.S. FDA Regarding Neupro® (Rotigotine) Stitcher Parkinson's Disease 0 04-29-2010 09:58 AM
NEWS: UCB Announces The U.S. Launch Of Neupro (Rotigotine Transdermal System) Stitcher Parkinson's Disease 0 07-19-2007 05:16 PM


All times are GMT -5. The time now is 03:53 AM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.